Biora Therapeutics, Inc.

BST:4ZU0 Stock Report

Market Cap: €17.4m

Biora Therapeutics Management

Management criteria checks 3/4

Biora Therapeutics' CEO is Adi Mohanty, appointed in Nov 2021, has a tenure of 2.92 years. total yearly compensation is $3.14M, comprised of 18.3% salary and 81.7% bonuses, including company stock and options. directly owns 4.03% of the company’s shares, worth €702.22K. The average tenure of the management team and the board of directors is 2.7 years and 3.3 years respectively.

Key information

Adi Mohanty

Chief executive officer

US$3.1m

Total compensation

CEO salary percentage18.3%
CEO tenure2.9yrs
CEO ownership4.0%
Management average tenure2.7yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Adi Mohanty's remuneration changed compared to Biora Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$87m

Mar 31 2024n/an/a

-US$111m

Dec 31 2023US$3mUS$574k

-US$124m

Sep 30 2023n/an/a

-US$122m

Jun 30 2023n/an/a

-US$64m

Mar 31 2023n/an/a

-US$52m

Dec 31 2022US$4mUS$550k

-US$49m

Sep 30 2022n/an/a

-US$118m

Jun 30 2022n/an/a

-US$140m

Mar 31 2022n/an/a

-US$176m

Dec 31 2021US$10mUS$63k

-US$179m

Compensation vs Market: Adi's total compensation ($USD3.14M) is above average for companies of similar size in the German market ($USD501.82K).

Compensation vs Earnings: Adi's compensation has been consistent with company performance over the past year.

CEO

Adi Mohanty (57 yo)

2.9yrs

Tenure

US$3,139,017

Compensation

Mr. Aditya P. Mohanty, also known as Adi,M.B.A. serves as Chief Executive Officer and Director at Biora Therapeutics, Inc. (formerly known as Progenity, Inc.) since November 8, 2021. Mr. Mohanty founded En...

Leadership Team

NamePositionTenureCompensationOwnership
Aditya Mohanty
CEO & Director2.9yrsUS$3.14m4.03%
$ 702.2k
Eric d'Esparbes
Chief Financial Officer5.4yrsUS$1.60m1.58%
$ 275.3k
Clarke Neumann
Senior VP10.1yrsUS$1.53m1.28%
$ 222.6k
Eric Fox
VP of Finance & Accounting & Treasurerno datano datano data
George Gianakopoulos
Senior Vice President of Sales5yrsno datano data
Robyn Hatton
Head of Human Resourcesno datano datano data
Kevin Howe
Senior VP of Strategic Operationsno datano datano data
Sharat Singh
Head of Research2.5yrsno datano data
Paul Shabram
Head of Technical Operations2.5yrsno datano data
Ariella Kelman
Chief Medical Officer1.4yrsno datano data
James Knight
Head of Business Developmentless than a yearno datano data

2.7yrs

Average Tenure

60yo

Average Age

Experienced Management: 4ZU0's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Aditya Mohanty
CEO & Director2.9yrsUS$3.14m4.03%
$ 702.2k
Brian Kotzin
Independent Director5.3yrsUS$185.11k0.050%
$ 8.7k
William Chey
Member of Clinical Advisory Board SIBO & Functional Bowel Disordersno datano datano data
Anthony Lembo
Member of Clinical Advisory Board SIBO & Functional Bowel Disordersno datano datano data
Geert D'Haens
Member of Inflammatory Bowel Disease Clinical Advisory Board3.3yrsno datano data
Bruce Sands
Chairman of Inflammatory Bowel Disease Clinical Advisory Board3.3yrsno datano data
Jeffrey Alter
Independent Chairman5.8yrsUS$208.11k0.052%
$ 9.1k
Mark Pimentel
Member of Clinical Advisory Board - SIBO & Functional Bowel Disordersno datano datano data
Lynne Powell
Independent Director5.7yrsUS$163.11k0.050%
$ 8.7k
Severine Vermeire
Member of Inflammatory Bowel Disease Clinical Advisory Board3.3yrsno datano data
Jill Howe
Independent Director2.9yrsUS$180.11k0.049%
$ 8.5k
Satish Rao
Chair of Clinical Advisory Board-SIBO/Functional Bowel Disordersno datano datano data

3.3yrs

Average Tenure

57yo

Average Age

Experienced Board: 4ZU0's board of directors are considered experienced (3.3 years average tenure).